Latest News about NVS
Recent news which mentions NVS
With Sandoz Spinoff, Novartis Slams Brakes On Huntington's Trial
August 25, 2022
Tickers
NVS
From Benzinga
From Benzinga
Fed heroics or no, the S&P 500 level is destined for a retest of lows. These are the levels to watch, says this strategist
August 25, 2022
From MarketWatch
Caribou's Blood Cancer Candidate Shows Response Rates Better Than Novartis,' This Analyst Writes
August 18, 2022
From Benzinga
A Look Into Healthcare Sector Value Stocks
August 15, 2022
From Benzinga
From Benzinga
From Benzinga
Deciphera's Cancer Drug Tops Pfizer's Sutent On Safety Front In Gastrointestinal Cancer
August 11, 2022
From Benzinga
Smaller Biotechs May Pave Way For New Generation Of Therapeutics For Hard-to-Treat Neurological Disorders
August 08, 2022
From Benzinga
From Benzinga
Tickers
NVS
From Motley Fool
Alnylam's Strategy Is Getting Bigger. Time to Buy?
July 30, 2022
From Motley Fool
From Benzinga
This Biotech Says Stem Cells May Be Key To Freeing 65 Million Americans From Chronic Back Pain, Painkiller Dependence
July 27, 2022
From Benzinga
7 Cathie Wood Stocks Trading at a Discount Right Now
July 26, 2022
From InvestorPlace
From Benzinga
From Benzinga
From Benzinga
What This FDA Delay Means for Novartis
July 21, 2022
From Motley Fool
From Benzinga
From Benzinga
From Benzinga
This Financial Services Stock Is Trading Higher By 50%, Here Are 40 Stocks Moving In Tuesday's Mid-Day Session
July 19, 2022
From Benzinga
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.